4.55 USD
↘ 0.35 (7.05%)AT CLOSE (11:59 AM EDT)
TransCode Therapeutics, Inc. Common Stock
RNAZNASDAQ • USD
4.57
↗ 0.02 (0.33%)
POST MARKET (AS OF 04:10 PM EDT)
Post Market
AS OF 04:10 PM EDT
4.57
↗ 0.02 (0.33%)
Market: CLOSED
Shares of TransCode Therapeutics, Inc. Common Stock (RNAZ) are trading at $4.53. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, RNAZ appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Jun 25, 2026.
Open?$4.80
High?$5.01
Low?$4.07
Prev. Close?$4.90
Volume?29.6K
Avg. Volume?101.0K
VWAP?$4.61
Rel. Volume?0.29x
Bid / Ask
Bid?$4.20 × 100
Ask?$5.48 × 100
Spread?$1.28
Midpoint?$4.84
Valuation & Ratios
Market Cap?4.7M
Shares Out?950.3K
Float?832.6K
Float %?90.8%
P/E Ratio?N/A
P/B Ratio?3.72
EPS?-$45.98
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
TransCode Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of RNA-based therapeutics and immuno-oncology treatments for cancer. The company's lead candidate, TTX-MC138, targets microRNA-10b and has completed a Phase 1a clinical trial, while it is also advancing additional product candidates, including a cancer vaccine and an oncolytic immunotherapy platform.
Themes
Employees
12
Market Cap
4.7M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2021-07-09
Address
6 LIBERTY SQUARE
BOSTON, MA 02109
Phone: 857-301-6857
BOSTON, MA 02109
Phone: 857-301-6857
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?23
Short Sent.?65
Piotroski F-Score?0/9Weak
Altman Z-Score?-1.62Distress
Confidence?45%Low
Short InterestElevated
Short % of Float?6.79%Elevated
Short Interest?56.5K
Days to Cover?1.0
Free Float832.6K
Avg Daily Volume230.7K
Settlement Date2026-06-15
Financial Health
Current Ratio?3.11Strong
Quick Ratio?3.11Strong
Cash Ratio?2.39Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?N/A▾
P/B?3.72FAIR▾
Peers100
S&P47
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?0.2CHEAP▾
Peers100
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-3,491.7%WEAK▾
S&P3
ROA?-27.8%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-21404249
Enterprise Value?$-8178974
Fundamentals ratios updated end of day